Results 31 to 40 of about 31,346 (264)

Impact of the Surgical Approach to Thymectomy Upon Complete Stable Remission Rates in Myasthenia Gravis

open access: yesNeurology, 2021
Objectives To determine whether the available operative techniques for thymectomy in myasthenia gravis (MG) confer variable chances for achieving complete stable remission (CSR), we performed a meta-analysis of comparative studies of surgical approaches ...
Paola Solis-Pazmino   +6 more
semanticscholar   +1 more source

The dilemma of thymectomy in myasthenia gravis

open access: yesApollo Medicine, 2020
Myasthenia gravis (MG) is an autoimmune disease that affects the neuromuscular junction causing fluctuating weakness of skeletal muscles. It is considered a rare disease with an estimated prevalence of 7.77/100,000.
Pushpendra Nath Renjen   +2 more
doaj   +1 more source

Comparing robotic and trans-sternal thymectomy for early-stage thymoma: a propensity score-matching study†

open access: yesEuropean Journal of Cardio-thoracic Surgery, 2018
Giuseppe Marulli   +2 more
exaly   +2 more sources

Prevalence and risk factors of myasthenia gravis recurrence post-thymectomy

open access: yesNeurosciences, 2021
Objectives: To evaluate the prevalence and the factors associated with recurrence of myasthenia gravis following thymectomy. Methods: Six electronic databases which reported on recurrence of myasthenia gravis following thymectomy and/or its risk factors ...
Fatmah Alqarni   +7 more
semanticscholar   +1 more source

Clinical characteristics of myasthenia gravis (MG) patients developing other autoimmune diseases after thymectomy from one single center cohort

open access: yesThoracic Cancer, 2023
Background Myasthenia gravis (MG) patients are reported to have a high risk of other autoimmune diseases (ADs), and thymectomy may increase the risk further.
Wenxin Tian   +9 more
doaj   +1 more source

Medically resistant juvenile myasthenia gravis following thymectomy: Role for FDG PET/CT

open access: yesJournal of Pediatric Surgery Case Reports, 2020
Thymectomy is part of a multimodal treatment strategy for juvenile myasthenia gravis. Symptoms that persist following thymectomy may be due to residual or ectopic thymic tissue.
Florence Ngu   +6 more
doaj   +1 more source

European multicentre study on outcome of surgery for sporadic primary hyperparathyroidism

open access: yesBJS (British Journal of Surgery), EarlyView., 2020
Some 5861 patients undergoing first‐time surgery for sporadic primary hyperparathyroidism were registered in the Eurocrine® database between 2015 and 2018. The use of intraoperative parathyroid hormone measurement decreased the risk of conversion and persistent hypercalcaemia.
A. Bergenfelz   +3 more
wiley   +1 more source

Thymoma‐associated myasthenia gravis: Clinical features and predictive value of antiacetylcholine receptor antibodies in the risk of recurrence of thymoma

open access: yesThoracic Cancer, 2021
Background Thymoma‐associated myasthenia gravis (TAMG) is one of the subtypes of myasthenia gravis with autoantibodies against the acetylcholine receptor (AChR‐Ab).
Anna De Rosa   +9 more
doaj   +1 more source

Thymectomy for myasthenia gravis: Video-assisted versus transsternal

open access: yesJournal of the Formosan Medical Association, 2014
Thymectomy may benefit patients with generalized myasthenia gravis (MG) or myasthenia with thymomas. Currently, video-assisted (VA) thoracic surgery is popular and plays an important role in thymectomy.
Chien-Ming Lo   +4 more
doaj   +1 more source

Regulation of autoimmunity and donor cell engraftment by recipient Lyt-2+ cells during the graft-versus-host reaction. [PDF]

open access: yes, 1987
When lymphocytes from DBA/2 mice are transferred to (C57BL X DBA/2)F1 (BDF1) mice, the ensuing graft-vs.-host reaction (GVHR) causes an autoimmune illness resembling human SLE.
Harper, SE, Roubinian, JR, Seaman, WE
core   +3 more sources

Home - About - Disclaimer - Privacy